Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 9 of these applications claim priority to application 61/307,797, filed Feb 24, 2010. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 8,557,966 | Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof In force · High confidence UsedRemaining | ImmunoGen, Inc. | In force | High confidence | ||
| US 9,598,490 | Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof In force · Medium confidence | ImmunoGen, Inc. | In force | Medium confidence | ||
| US 9,657,100 | Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof In force · Medium confidence | ImmunoGen, Inc. | In force | Medium confidence | ||
| US 9,670,278 | Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof In force · Medium confidence | ImmunoGen, Inc. | In force | Medium confidence | ||
| US 9,670,279 | Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof In force · Medium confidence | ImmunoGen, Inc. | In force | Medium confidence | ||
| US 9,670,280 | Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof In force · Medium confidence | ImmunoGen, Inc. | In force | Medium confidence | ||
| US 10,752,683 | Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof In force · High confidence | ImmunoGen, Inc. | In force | High confidence | ||
| US 10,301,385 | Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof In force · High confidence | ImmunoGen, Inc. | In force | High confidence | ||
| US 9,133,275 | Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof In force · Medium confidence | ImmunoGen, Inc. | In force | Medium confidence | ||
| Application 16/934,143 | Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof Abandoned Abandoned Dec 29, 2023 | ImmunoGen, Inc. | Abandoned | Abandoned Dec 29, 2023 | ||
| 1 more record in this group · Pro | ||||||
10 of 11 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 11.
9 of these are in force and held by ImmunoGen, Inc..
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.